SPY313.28+2.76 0.89%
DIA259.37+2.06 0.80%
IXIC10,248.55+93.92 0.92%

SunTrust Robinson Humphrey Assumes Dicerna Pharmaceuticals at Buy, Raises $24 Price Target

SunTrust Robinson Humphrey assumes Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy rating and a $24 price target.

Benzinga · -

SunTrust Robinson Humphrey assumes Dicerna Pharmaceuticals (NASDAQ:DRNA) with a Buy rating and a $24 price target.